Navigating Critical Pathways: Ensuring Optimal Management of Acute Coronary Syndrome
Activity Date: August 2007  — Activity Info: Volume4, (7)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

To provide hospital pharmacists with up-to-date information regarding their role in the management and treatment of patients with acute coronary syndrome.

This activity is designed for hospital pharmacists. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Describe the burden of acute coronary syndrome (ACS) and the pharmacist’s role in quality assurance and continuum of care.
  • Evaluate efficacy of pathway-based quality improvement interventions on appropriate management of ACS.
  • State the impact of guidelines and clinical trials on the treatment of patients presenting with unstable angina (UA) or non–ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI) in conjunction with risk stratification.
  • List evidence-based pharmacotherapeutic and nonpharmacologic management methods for UA/NSTEMI and STEMI.
  • Recommend antithrombotic therapies and education for a patient with ACS at the time of discharge from the hospital.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council of Pharmacy Education (ACPE) to provide continuing education for pharmacists.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE program # 064-000-07-212-H01-P

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy  Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity: 2 hours.

Release date: August 1, 2007. Expiration date: August 1, 2009.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs,  including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or cosponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.
Home | Contact Us | View Account | Need Help?